SB-204,741
SB-204,741 je lek koji deluje kao potentan i selektivan antagonist na serotoninskom 5-HT2B receptoru, sa oko 135x selektivnošću u odnosu na blisko srodni 5-HT2C receptor, i još većom u odnosu na 5-HT2A receptor.[1] On se koristi u naučnim istraživanjima za ispitivanje funkcije 5-HT2B receptora.[2][3][4][5]
IUPAC ime | |
---|---|
N-(1-Metil-1H-indol-5-il)-N'-(3-metilizotiazol-5-il)ureja | |
Identifikatori | |
CAS broj | 152239-46-8 |
ATC kod | none |
PubChem | CID 3277600 |
IUPHAR/BPS | 221 |
Sinonimi | SB-204,741 |
Hemijski podaci | |
Formula | C14H14N4OS |
Molarna masa | 286,352 g/mol |
|
Reference уреди
- ^ Forbes, IT; Jones, GE; Murphy, OE; Holland, V; Baxter, GS (1995). „N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea: a novel, high-affinity 5-HT2B receptor antagonist”. Journal of Medical Chemistry. 38 (6): 855—7. PMID 7699699. doi:10.1021/jm00006a001.
- ^ Glusa, E; Pertz, HH (2000). „Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT2B receptors”. British Journal of Pharmacology. 130 (3): 692—8. PMC 1572101 . PMID 10821800. doi:10.1038/sj.bjp.0703341.
- ^ Holohean, AM; Hackman, JC (2004). „Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones”. British Journal of Pharmacology. 143 (3): 351—60. PMC 1575347 . PMID 15339859. doi:10.1038/sj.bjp.0705935.
- ^ Papageorgiou, A; Denef, C (2007). „Stimulation of growth hormone release by 5-hydroxytryptamine (5-HT) in cultured rat anterior pituitary cell aggregates: evidence for mediation by 5-HT2B, 5-HT7, 5-HT1B, and ketanserin-sensitive receptors”. Endocrinology. 148 (9): 4509—22. PMID 17584957. doi:10.1210/en.2007-0034.
- ^ Wouters, MM; Gibbons, SJ; Roeder, JL; Distad, M; Ou, Y; Strege, PR; Szurszewski, JH; Farrugia, G (2007). „Exogenous serotonin regulates proliferation of interstitial cells of Cajal in mouse jejunum through 5-HT2B receptors”. Gastroenterology. 133 (3): 897—906. PMID 17854596. doi:10.1053/j.gastro.2007.06.017.